Finland· FI-REL-REL2684
Reodyn
A carbocisteine product containing carbocysteine, registered in Finland by Orion Corporation. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Carbocisteine is registered in 9 of 19 countries.
Countries holding a registration under ATC R05CB03 (carbocisteine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Carbocisteine · ATC R05CB03
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Carbocysteine
- Manufacturer
- Orion Corporation
- Country
- Finland (FI)
- ATC code
- R05CB03
- ATC class
- Carbocisteine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbocisteine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCARBOCISTEINA MABO 50 MG/ML SOLUCION ORALMabo Farma S.A.
- IrelandExpudyne 250 mg/5 ml oral solutionJed Pharma Limited
- FranceBRONCHEX 750 mg/15 ml ADULTES SANS SUCRE, solution buvable en sachet édulcorée à la saccharine sodique et au maltitol liquideLIBERTY PHARMA (LUXEMBOURG)
- BelgiumSiroxyl Carbocisteïne Zonder Suiker 250 mg/5 mlMelisana
- NetherlandsMucodyne Adult 50 mg/ml, hoestdrankVEMEDIA Manufacturing B.V.
- PolandFlegamaxZakłady Farmaceutyczne POLPHARMA S.A.
- United KingdomCarbocisteine 250mg/5ml oral solutionBrown & Burk UK Ltd
- JapanＬ－カルボシステイン鶴原製薬
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Muco Rhinathiol Erwachsene, Zuckerfrei, Muco Rhinathiol Adultes
- Bulgaria · Fluditec, Бронлес
- Cyprus · Pulmoclase “χωρίσ Ζάχαρη”
- Estonia · Fluditec
- Spain · Actithiol Mucolítico Infantil, Cinfamucol
- France · Broncathiol, Bronchokod Adultes Édulcorée À La Saccharine Sodique Et Au Maltitol Liquide
- United Kingdom (Northern Ireland) · Carbocisteine, Carbocisteine Accord
- Greece · Chilvax, Drizak
- Croatia · Bronles, Karbocistein Alpha-Medical
- Hungary · Lolimucin, Mucopront
- Ireland · Benylin Mucus Relief, Expudyne
- Italy · Coryfin Tosse Mucolitico, Katarfluid Adulti
- Lithuania · Fluditec
- Luxembourg · Muco Rhinathiol Adultes, Muco Rhinathiol Adultes, Sans Sucre
- Latvia · Fluditec
- Malta · Pulmoclase «sugar Free», Xtex
- Netherlands · Mucodyne Adult, Mucodyne Junior
- Poland · Auropect, Auropect Comfort
- Portugal · Finatux, Griflux
- Romania · Fluidol, Rhinathiol Pentru Copii
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9ef683f7-c152-49ee-97d5-5f50dd7032a8 GET /v1/drugs/9ef683f7-c152-49ee-97d5-5f50dd7032a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.5",
"form": "oraaliliuos",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "50 mg/ml",
"atc_label": "karbosisteiini",
"ma_number": "10183",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2684",
"authorised_at": "1990-03-14"
}See everything about carbocisteine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.